Clinical trial
PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas…
NCT00467116 · Vanderbilt-Ingram Cancer Center, Other · Completed
Key facts
| NCT number | NCT00467116 |
|---|---|
| Title | PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca |
| Official title | A Phase I Study of Erbitux and Gemcitabine With Radiation Therapy for Locally Advanced Pancreas Cancer |
| Lead sponsor | Vanderbilt-Ingram Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Biological, Drug, Radiation |
| Interventions | cetuximab, gemcitabine hydrochloride, radiation therapy |
| Enrollment | 9 |
| Start date | Oct 1, 2005 |
| Primary completion | Aug 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Apr 27, 2007 |
| Last update posted | May 18, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: